Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Warren E. Grupe is active.

Publication


Featured researches published by Warren E. Grupe.


The New England Journal of Medicine | 1976

Chlorambucil Treatment of Frequently Relapsing Nephrotic Syndrome

Warren E. Grupe; Sudesh P. Makker; Julie R. Ingelfinger

Chlorambucil, in combination with prednisone, was compared with prednisone alone in a randomized controlled trial in 21 children with either steroid-dependent or frequently relapsing nephrotic syndrome to assess its effect on the duration of remission and the rate of relapse. All control patients treated with prednisone alone continued to relapse at the same rate, with all patients experiencing a return of proteinuria by seven months. Conversely, those who received the same prednisone therapy along with chlorambucil for six to 12 weeks remained in complete remission, without further medication, during 12 to 34 months of follow-up observation. Complications were minimal. Immediate side effects commonly reported with cyclophosphamide were not seen with chlorambucil. Comparison with published reports also suggests that remission induced by chlorambucil is more stable than that after cyclophosphamide. Chlorambucil appears to be of value in the frequently relapsing nephrotic patient, adding an effect that is unattainable with prednisone alone.


The New England Journal of Medicine | 1979

Chronic renal failure in children treated with methyl CCNU.

William E. Harmon; Harvey J. Cohen; Eveline E. Schneeberger; Warren E. Grupe

METHYL CCNU (1- [2-chloroethyl] -3-[4-methyl cyclohexylj-1-nitrosourea) has been used to treat a variety of solid tumors1 2 3 for more than six years.4 It has been shown to be effective and to have...


The New England Journal of Medicine | 1980

Long-Term Evaluation of Chlorambucil plus Prednisone in the Idiopathic Nephrotic Syndrome of Childhood

Susan A. Williams; Sudesh P. Marker; Julie R. Ingelfinger; Warren E. Grupe

We evaluated the long-term effects of a five to 15-week course of chlorambucil and prednisone in 59 children with idiopathic nephrotic syndrome who had previously received prednisone alone and had had frequent relapses or steroid dependency or resistance. By actuarial analysis of 65 courses of dual therapy followed up for one to 12 years (mean, 5.0), we found that 95 per cent of patients were in remission at one year and 85 per cent at four years. All but two had remissions lasting longer than those induced by steroids alone, and only eight others had one or more relapses after therapy. Life-table analysis of two dosage schedules of chlorambucil at four years showed that 91 per cent of patients on low doses and 80 per cent of those on high doses were still in remission. Although immediate complications were minimal, the potential for long-term toxicity still requires careful selection of patients who receive chlorambucil. Prolonged use of chlorambucil in daily doses above 0.3 mg per kilogram of body weight per day or cumulative doses above 14 mg per kilogram is no longer warranted. Measured in terms of both the immediate and long-term responses, chlorambucil appears to lower the frequency of relapses in idiopathic nephrotic syndrome.


Pediatric Nephrology | 1987

Nutritional management of children with chronic renal failure. Summary of the task force on nutritional management of children with chronic renal failure.

Stanley Hellerstein; Malcolm A. Holliday; Warren E. Grupe; Richard N. Fine; Robert S. Fennell; Russell W. Chesney; James C. M. Chan

Current information on the adaptations to progressive loss of renal function is presented. The assessment of renal function in infants and children using serum creatinine concentration and its derivatives is considered as are various methods for assessment of growth. Children with creatinine clearances less than 50% of normal, who do not have uremic symptoms (and who are not on dialysis), should be ingesting diets providing close to 100% of the RDA for calories with 8% of the calories as protein. Recommendations for nutritional management of children on chronic peritoneal dialysis are also presented.


The Journal of Pediatrics | 1977

Necrotizing arteritis in acute poststreptococcal glomerulonephritis: report of a recovered case.

Julie R. Ingelfinger; Robert T. McCluskey; Eveline E. Schneeberger; Warren E. Grupe

A patient with biopsy documented acute poststreptococcal glomerulonephritis and arteritis recovered completely with supportive therapy. Illness was preceded by group A streptococcal pharyngitis. At the time of presentation, serum creatinine concentration was 11.5 mg/dl. Serum cryoglobulins containing IgG and C3 were present. The first biopsy, performed during the acute illness, contained glomeruli with typical features of acute PSGN. Medium-sized arteries had extensive necrosis and leukocytic infiltration, and contained IgG, C3, and fibrin. Glomerular filtration rate returned to normal within three weeks; proteinuria cleared by three months, and microscopic hematuria by 11 months. Renal biopsy one year later showed minimal mesangial hypercellularity and no arteritis.


Dermatology | 1977

Warts in a Pediatric Renal Transplant Population

Julie R. Ingelfinger; Warren E. Grupe; Michele Topor; Raphael H. Levey

18 of 49 pediatric renal transplant recipients, all of whom were on continual steroid and immunosuppressive treatment, were found to have warts. Although all 18 patients received treatment for this problem, only 5 had the warts successfully eradicated. The frequency of warts among transplant patients is three times that of the general childhood population and twice that of a group of nephrotic pediatric patients who received immunosuppressive therapy. We propose that drug-induced suppression of cell-mediated, and to a lesser extent, humoral immunity, may predispose people to develop warts.


Journal of Parenteral and Enteral Nutrition | 1980

Complications of essential amino acid hyperalimentation in children with acute renal failure.

Kathleen J. Motil; William E. Harmon; Warren E. Grupe

The metabolic effects of intravenous hyperalimentation, using an essential amino acid (EAA) and glucose solution, were evaluated in 2 children with acute renal failure. Hyperammonemia and hyperchloremic metabolic acidosis associated with elevated plasma methionine and depressed plasma citrulline, ornithine, arginine, and histidine levels complicated the nutritional therapy. Initial infusion of a complete amino acid (CAA) solution was not associated with these aberrations and reintroduction of a CAA solution after the EAA trial resulted in a progressive amelioration of or complete recovery from these metabolic disturbances. It is likely that the hyperammonemia was due to an arginine deficiency, while excess methionine and presumably sulfate production may have contributed to the hyperchloremic metabolic acidosis in these two children.


The Journal of Urology | 1983

An Organ Culture Model for the Study of Metanephric Development

Ellis D. Avner; Dorothy B. Villee; Eveline E. Schneeberger; Warren E. Grupe

A murine whole organ metanephric culture system was designed to study the developmental aspects of mammalian nephrogenesis. Metanephros and ureteric bud were removed from CFI albino mouse embryos at 13.5 +/- 0.4 days gestation, and grown in Dulbeccos modified Eagles Minimal Essential Medium supplemented with 20 per cent donor bovine serum at 37C in a mixed air--5 per cent CO2 environment. Under the experimental conditions employed, the metanephric explants showed organotypic tubular and glomerular epithelial development. A well-developed proximal tubule with microvilli, and characteristic intracellular organelles and intercellular junctions developed by 72 hours of culture. By 120 hours of culture, unique devascularized glomeruli consisting of parietal and visceral epithelial layers formed. The glomerular visceral epithelial cells formed foot processes and slit pore diaphragms, and produced islands of basement membrane. No endothelial or mesangial elements were present at any stage in organ culture development, indicating that advanced nephrogenesis can occur following initial epithelial-mesenchymal induction despite the absence of vascularization. The whole organ culture model system isolates renal structural development from the influences of perfusion and urine formation. The system thus affords the opportunity to study normal, as well as abnormal mammalian renal development under highly controlled experimental conditions.


The American Journal of Medicine | 1977

Mesangial proliterative glomerulonephritis with irregular intramembranous deposits: Another variant of hypocomplementemic nephritis

Alvin E. Davis; Eveline E. Schneeberger; Robert T. McCluskey; Warren E. Grupe

Abstract Two patients with a persistent mesangial proliferative glomerulonephritis and reduced serum C3 levels have been followed for six and 10 years. Both have had a mild course with normal renal function and spontaneous morphologic improvement. Levels of the fourth component (C4) and second component (C2) of complement, and properdin factor B have been normal; the third component (C3) of complement nephritic factor has not been detected. Ultrastructurally, irregular intramembranous electron-dense deposits are present, primarily within the lamina densa. These deposits are separated by varying lengths of normal-appearing glomerular basement membrane. Intramembranous and subendothelial electron-lucent areas, containing vesicles, are also seen. Subendothelial deposits, mesangial interposition, splitting of the glomerular basement membrane and ribbon-like intramembranous deposits are not found. The disease in these patients was clinically indistinguishable at onset from membranoproliferative glomerulonephritis (MPGN). The possibility of a variant with mild clinical course, no progression and spontaneous morphologic improvement is important in planning and assessing treatment programs in this disease group.


Journal of Pediatric Surgery | 1978

Unique surgical and immunologic features of renal transplantation in children

Raphael H. Levey; Julie R. Ingelfinger; Warren E. Grupe; Michele Toper; Angelo J. Eraklis

We have performed 93 renal allografts in recipients having a mean age of 12.6 yr. Sixty percent of the kidneys were from parental donors, 10 from siblings, and 30 from cadavers. Young children present unique surgical, hemodynamic, and immunologic management problems. Modifications of standard transplantation surgical techniques have been developed that allow for routine retroperitoneal placement of adult kidneys in patients as young as 2.4 yr. These modifications include the surgical incision itself, the vascular anastomosis, and the operations urologic components. Fluid management must allow maximum perfusion of the adult organ without compromise of the childs cardiovascular system. The most critical aspects of the undertaking reside in immunologic matching of the donor-recipient pair and in postoperative immunosuppression. Parent-to-child combinations usually share one HLA haplotype, are stimulatory in mixed lymphocyte cultures, and produce killing in cell-mediated lympholysis assays. Traditional wisdom predicts an unfavorable outcome with such allografts. Immunosuppression has been predicated on the outcome of these tests. In unfavorable parent-to-child pairs, and when poorly matched cadaveric kidneys are used, we have routinely employed a prolonged postoperative intravenous course of whole rabbit antihuman thymocyte sera prepared in our institution. The results show that in both situations the 1-yr kidney survival is 92%. Early rejection episodes have essentially been eliminated, and with them the need for large increments in steroid dosage. The children have eventually been placed on alternate-day steroid therapy, thus allowing for as near normal growth and development as possible. The data indicate not only that the very young child with endstage renal disease is an appropriate recipient for a renal allograft but also that growth failure itself may be an indication for early transplantation.

Collaboration


Dive into the Warren E. Grupe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan M. Krensky

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Russell W. Chesney

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ellis D. Avner

Medical College of Wisconsin

View shared research outputs
Researchain Logo
Decentralizing Knowledge